IDEXX Laboratories, Inc.

Equities

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
486 ^USD	+1.78%		-0.25%	-12.44%

Jun. 24	Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $520	MT
May. 29	Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 10:55 AM

IDEXX Laboratories : to Release 2018 Fourth Quarter and Full-Year Financial Results

January 09, 2019 at 04:21 pm EST

WESTBROOK, Maine, Jan. 9, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 fourth quarter and full-year financial results for Friday, February 1, 2019 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.

Individuals can access a live webcast of the conference call through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the webcast will be available after 1:00 p.m. ET on that day via the same link and will remain available for one year.

The live call also will be accessible by telephone. To listen to the live conference call, please dial 1-800-230-1074 or 1-612-234-9960 and reference confirmation code 462085. Replay of the conference call will be available through Friday, February 8, 2019 by dialing 1-800-475-6701 or 1-320-365-3844 and referencing replay code 462085.

IDEXX Laboratories, Inc. logo. (PRNewsFoto/IDEXX Laboratories, Inc.)

About IDEXX Laboratories
IDEXX Laboratories, Inc. is a member of the S&P 500^® Index and is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX employs more than 8,000 people and offers products to customers in over 175 countries. For more information about IDEXX, visit: www.idexx.com.

Contact: Kerry Bennett, Investor Relations, 1-207-556-8155

View original content to download multimedia:http://www.prnewswire.com/news-releases/idexx-laboratories-to-release-2018-fourth-quarter-and-full-year-financial-results-300775930.html

SOURCE IDEXX Laboratories, Inc.

Latest news about IDEXX Laboratories, Inc.

Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $520	Jun. 24	MT
Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference, May-29-2024 10:55 AM	May. 29
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620	May. 14	MT
BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653	May. 02	MT
Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675	May. 02	MT
Stifel Adjusts Price Target on IDEXX Laboratories to $520 From $570	May. 02	MT
Barclays Adjusts Price Target on IDEXX Laboratories to $570 From $655	May. 02	MT
Redburn Atlantic Adjusts Price Target on IDEXX Laboratories to $500 From $460	May. 02	MT
Wall Street: heaviness prevails after a volatile episode	May. 01	CF
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	May. 01	CI
IDEXX Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
Transcript : IDEXX Laboratories, Inc., Q1 2024 Earnings Call, May 01, 2024	May. 01
IDEXX Laboratories' Q1 Earnings, Revenue Increase	May. 01	MT
Earnings Flash (IDXX) IDEXX LABORATORIES Posts Q1 Revenue $964.1M, vs. Street Est of $965.8M	May. 01	MT
Idexx Laboratories, Inc. Revises Earnings Guidance for 2024	May. 01	CI
North American Morning Briefing : Traders Wait for -2-	May. 01	DJ
BofA Securities Cuts Price Target on IDEXX Laboratories to $595 From $600, Maintains Neutral Rating	Apr. 30	MT
Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board	Apr. 01	MT
Elanco appoints two directors after settling with activist Ancora	Apr. 01	RE
Elanco appoints two directors to its board after agreement with Ancora	Apr. 01	RE
Idexx Laboratories: Superior growth prospects	Mar. 11
Idexx Laboratories Insider Sold Shares Worth $790,427, According to a Recent SEC Filing	Mar. 07	MT
Idexx Laboratories Insider Sold Shares Worth $4,525,596, According to a Recent SEC Filing	Mar. 07	MT
Transcript : IDEXX Laboratories, Inc. Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-04-2024 11:00 AM	Mar. 04
Ancora seeks four board seats at Elanco amid push for changes	Feb. 29	RE

Chart IDEXX Laboratories, Inc.

Duration

Period

More charts

Company Profile

IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.6%); - water quality analysis (4.6%); - veterinary diagnoses for livestock and poultry (3.3%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.5%). Net sales by source of income break down between product sales (57.1%) and services (42.9%). Net sales are distributed geographically as follows: the United States (65.3%), Canada (4.1%), Americas (2.3%), Germany (4.1%), the United Kingdom (3.3%), France (2.7%), Italy (1.5%), Spain (1.4%), Switzerland (0.9%), the Netherlands (0.8%), Europe/Middle East/Africa (4.8%), Australia (2.6%), Japan (2.1%), China (1.2%) and Asia/Pacific (2.9%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-06 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company